-
公开(公告)号:EP3851537A1
公开(公告)日:2021-07-21
申请号:EP21151019.3
申请日:2015-04-27
摘要: The invention relates to a nucleic acid sequence useful in the treatment of hyperbilirubinemia, in particular in the treatment of Crigler-Najjar syndrome. More particularly, the nucleic acid sequence of the present invention is a codon-optimized UGT1A1 coding sequence.
-
公开(公告)号:EP3134530B1
公开(公告)日:2019-06-12
申请号:EP15719677.5
申请日:2015-04-27
-
公开(公告)号:EP3134530A2
公开(公告)日:2017-03-01
申请号:EP15719677.5
申请日:2015-04-27
CPC分类号: A61K38/45 , A61K48/0058 , A61K48/0066 , C12N7/00 , C12N9/1051 , C12N15/86 , C12N2750/14143 , C12N2830/008 , C12N2830/42 , C12Y204/01017
摘要: The invention relates to a nucleic acid sequence useful in the treatment of hyperbilirubinemia, in particular in the treatment of Crigler-Najjar syndrome. More particularly, the nucleic acid sequence of the present invention is a codon-optimized UGT1A1 coding sequence.
摘要翻译: 本发明涉及可用于治疗高胆红素血症的核酸序列,特别是治疗克里格勒 - 纳济氏综合症。 更具体地,本发明的核酸序列是密码子优化的UGT1A1编码序列。
-
公开(公告)号:EP3546585A1
公开(公告)日:2019-10-02
申请号:EP19172023.4
申请日:2015-04-27
摘要: The invention relates to a nucleic acid sequence useful in the treatment of hyperbilirubinemia, in particular in the treatment of Crigler-Najjar syndrome. More particularly, the nucleic acid sequence of the present invention is a codon-optimized UGT1A1 coding sequence.
-
5.
公开(公告)号:EP4176064A1
公开(公告)日:2023-05-10
申请号:EP21735991.8
申请日:2021-07-05
申请人: GENETHON , Institut National de la Santé et de la Recherche Médicale (INSERM) , Universite d'Evry Val d'Essonne
IPC分类号: C12N15/86 , C07K14/005
-
公开(公告)号:EP3293259A1
公开(公告)日:2018-03-14
申请号:EP16306148.4
申请日:2016-09-12
IPC分类号: C12N9/26
CPC分类号: C12N9/2408 , C07K2319/02 , C07K2319/036
摘要: The present invention relates to variants of acid-alpha glucosidase and uses thereof. Said variants are sequence-optimized and/or are linked to a heterogenous signal peptide.
摘要翻译: 本发明涉及酸-α葡糖苷酶的变体及其用途。 所述变体经过序列优化和/或连接至异源信号肽。
-
公开(公告)号:EP4381077A1
公开(公告)日:2024-06-12
申请号:EP22761183.7
申请日:2022-08-04
申请人: GENETHON , Université d'Evry Val d' Essonne , Institut National de la Santé et de la Recherche Médicale (INSERM)
发明人: RONZITTI, Giuseppe , VIDAL, Pauline
CPC分类号: C12N2750/1414320130101 , C12N15/86 , C12N2830/00820130101 , A61K48/0058 , A61K48/005
-
公开(公告)号:EP4361178A2
公开(公告)日:2024-05-01
申请号:EP23208091.1
申请日:2017-09-12
申请人: Genethon , Sorbonne Université , INSERM - Institut National de la Santé et de la Recherche Médicale , Association Institut de Myologie , Centre National de la Recherche Scientifique
IPC分类号: C07K16/44
CPC分类号: C12Y302/0102 , C12N9/2408 , C07K2319/0220130101 , C07K2319/0620130101 , A61P3/00 , A61P43/00
摘要: The present invention relates to variants of acid-alpha glucosidase and uses thereof.
-
公开(公告)号:EP3952920A1
公开(公告)日:2022-02-16
申请号:EP20715417.0
申请日:2020-04-07
-
公开(公告)号:EP3833746A1
公开(公告)日:2021-06-16
申请号:EP19746522.2
申请日:2019-08-06
申请人: Genethon , Institut National de la Santé et de la Recherche Médicale , Sorbonne Université , Universite d'Evry Val d'Essonne , Association Institut de Myologie
IPC分类号: C12N9/00
-
-
-
-
-
-
-
-
-